Stifel Nicolaus Starts Johnson & Johnson with a "Hold" Rating (JNJ)

Stifel Nicolaus Starts Johnson & Johnson with a “Hold” Rating (JNJ)

RSS

Analysts at Stifel Nicolaus initiated coverage on Johnson & Johnson (JNJ) on Tuesday.

Stifel Nicolaus noted, “We are initiating coverage of Johnson & Johnson (JNJ) with a Hold rating. We see JNJ as a core health care holding and total return vehicle in any environment for investors looking for safety and stability, particularly in these uncertain times. As JNJ continues to resolve recent issues and ex-FX sales growth reaccelerates modestly in each year over the next few years, JNJ shares should sustain its 12.6x forward P/E multiple, in line with the S&P 500.”

Johnson & Johnson shares were down 24 cents, or -0.34%, in premarket trading on Wednesday.

The Bottom Line
We have been recommending shares of Johnson & Johnson (JNJ) since Apr.27, when the stock was trading at $64.75. The company has a 3.50% dividend yield, based on last night’s closing stock price of $69.67.

Johnson & Johnson (JNJ) is recommended at this time, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from Dividend.com.

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today